rfhg_110297.1

Basic information about the TSS

---

TSS ID: rfhg_110297.1 Species: human Chr: chr8		Start: 120445369 End: 120445410 Strand: -
Source datasets	PRJNA401781|PRJDB5282|PRJNA4843412|DRA013844|PRJNA615891 |PRJNA548673
Protocol	oligo_capping|C1CAGE|NETCAGE|CAGE|RAMPAGE|TIF-seq2 |ReCappable-seq
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4140694,EH38E2661096)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000518696.5:0 BC021744:0 GeneID: 28998 HGNC/MGI_ID: HGNC:14278 UniProt_ID: E5RFI2 Nearer transcript ids and distances: LF210272:-190 MA445849:-190 AK311924:210 ENST00000306185.8:219 NM_014078.6:219 BC009190:231 AF112214:233 AB049640:236 AK307322:264 ENST00000520677.1:270 DQ893117:275 DQ893487:275 KJ893669:275 DQ896395:275 CU692406:275 ENST00000518918.1:277 view more...

Gene_name: mitochondrial ribosomal protein L13 Gene_symbol: MRPL13 Gene_synonyms: L13 L13A L13mt RPL13 RPML13 Gene_source: HGNC:14278

TATA-Box annotation

---

Distance to TSS:	-30
Nearest PromoterID:	NM_022045
Entrez ID:	27085
Nearest Unigene:	Hs.657656
Nearest Refseq:	NM_022045
Nearest Ensembl:	ENSG00000172167
Gene Name:	mitochondrial ribosomal protein L13
Gene Alias:	MDM2BP
Gene Type:	protein-coding
CpG%:	0.097561
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MRPL13 p2@MRPL13 p3@MRPL13 p4@MRPL13
Sample		p1@MRPL13	p2@MRPL13	p3@MRPL13	p4@MRPL13
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.82	48.12	5.45	6.82
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.44	43.70	5.06	6.47
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.16	48.23	4.63	9.84
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	31.19	43.25	6.24	5.82
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	36.89	40.94	8.10	5.85
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.21	36.63	5.81	6.59
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	63.19	56.43	9.80	8.72
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.75	59.10	10.90	7.75
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	45.52	48.73	8.76	7.69
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	34.20	60.28	11.59	8.69
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.13	39.21	10.11	5.66
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	39.84	7.32	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.57	14.02	2.10	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.23	10.52	1.95	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.00	15.59	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.09	12.57	2.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.01	10.48	2.18	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	12.65	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	14.40	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.15	13.84	2.71	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	14.30	1.87	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.98	11.91	2.42	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.54	12.28	2.07	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.56	12.13	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.03	15.74	2.06	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.41	16.46	2.85	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	11.54	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.45	15.80	4.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.54	12.60	2.42	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.93	15.02	1.99	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.63	14.44	1.47	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.63	13.48	2.34	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.29	12.03	1.06	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.48	20.29	4.45	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.45	14.96	2.99	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.33	10.92	2.30	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.58	17.99	2.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.12	12.69	3.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.94	19.72	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.72	18.00	3.12	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.23	12.00	3.53	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.37	20.06	2.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.61	17.72	3.16	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.36	14.69	4.37	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.67	22.69	6.02	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.17	31.64	3.49	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.83	18.47	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.63	27.42	3.87	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.52	17.95	3.11	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.43	19.21	3.03	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.19	19.06	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.68	19.57	2.45	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	83.95	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.42	13.48	2.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.26	21.54	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	28.52	72.15	8.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	20.67	33.07	4.59	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.40	15.23	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	16.70	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.17	39.61	5.97	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	12.69	11.99	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.09	9.53	2.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	37.42	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	19.71	4.42	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.97	10.07	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.87	10.29	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	64.66	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	94.77	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	7.80	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	13.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	7.51	2.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.21	18.88	2.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	15.47	1.55	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.54	8.87	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	20.11	11.72	3.64	1.11
Adipocyte - breast, donor2	11327-117E4	23.42	18.61	2.41	1.44
Adipocyte - omental, donor1	11473-119C6	20.74	17.68	3.18	2.42
Adipocyte - omental, donor2	11474-119C7	18.69	32.14	4.48	1.49
Adipocyte - omental, donor3	11475-119C8	21.10	24.78	1.34	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.23	21.69	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	6.60	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.55	11.29	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	14.25	7.99	1.22	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	16.62	14.86	2.54	1.96
Adipocyte differentiation, day04, donor2	13022-139D7	12.35	15.70	1.29	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.84	13.38	1.39	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	11.17	14.11	2.94	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	22.12	16.09	2.49	2.57
Adipocyte differentiation, day08, donor2	13023-139D8	18.72	17.11	1.29	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	8.53	10.13	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	16.69	2.23	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	19.55	3.33	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	17.58	18.84	3.27	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	10.47	0.98	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	9.74	1.52	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	22.54	19.89	1.55	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	3.59	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.33	8.46	1.44	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	15.06	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.71	14.38	1.23	0.62
Anulus Pulposus Cell, donor1	11248-116E6	21.05	18.88	3.20	1.95
Anulus Pulposus Cell, donor2	11463-119B5	14.45	15.67	1.22	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	19.32	3.15	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.40	23.01	2.60	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	40.66	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.25	17.64	3.29	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	24.03	2.53	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	14.52	3.30	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.14	21.44	3.57	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	24.27	1.94	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.85	20.79	2.97	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.60	18.08	3.39	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.96	15.96	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	17.55	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.16	15.49	0.99	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	24.57	4.09	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.79	16.29	4.37	1.81
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	17.15	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.44	20.59	2.46	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.84	18.44	3.47	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	12.68	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.75	17.08	1.66	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	14.41	4.80	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	21.24	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.72	18.70	2.23	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.79	25.73	2.43	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.21	20.87	4.93	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	15.75	3.63	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	15.96	3.42	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.32	15.82	3.63	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	16.00	2.06	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.30	18.30	4.22	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.76	16.40	2.57	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	14.98	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.21	16.96	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.88	23.48	3.31	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	22.57	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.83	28.48	5.09	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.16	23.94	3.82	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	17.79	3.18	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	17.26	20.28	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	18.21	16.30	3.39	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.69	13.63	3.19	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	24.56	1.89	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.43	15.77	2.54	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	13.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	23.24	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.94	17.15	2.57	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	18.05	1.80	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	21.87	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.39	18.39	3.91	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	12.75	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.56	24.66	4.58	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.37	18.17	4.75	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.38	19.58	2.45	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.82	22.94	3.35	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.40	20.62	2.22	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	16.78	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.95	21.60	4.43	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.27	17.21	2.65	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.26	16.36	3.27	2.54
Astrocyte - cerebellum, donor1	11500-119F6	13.39	15.84	0.61	2.09
Astrocyte - cerebellum, donor2	11580-120F5	11.13	11.47	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	5.45	5.24	0.42	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	38.34	21.61	3.14	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	34.46	20.55	2.91	2.91
Astrocyte - cerebral cortex, donor3	11392-118C6	36.99	22.67	2.54	4.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	58.83	41.29	4.36	4.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	69.66	53.62	7.02	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	70.90	53.48	6.71	3.30
Basophils, donor1	12241-129G9	5.23	4.97	1.57	0.00
Basophils, donor2	12242-129H1	15.15	9.38	2.89	0.36
Basophils, donor3	12243-129H2	6.91	3.97	1.47	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	7.11	10.56	2.59	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	21.52	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	45.82	2.51	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	6.65	5.82	0.00	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	14.05	13.59	1.84	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	26.09	32.93	7.02	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	44.62	27.10	8.55	2.58
Burkitt's lymphoma cell line:RAJI	10476-106I8	61.02	64.75	7.69	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.34	21.11	3.52	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.94	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	5.20	2.78	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	8.12	2.85	1.10	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.25	16.70	3.11	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.03	14.40	3.03	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	18.41	16.77	2.30	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	7.81	10.41	2.17	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	6.03	6.64	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	11.37	13.27	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.02	3.35	0.84	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.24	6.07	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.71	4.46	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.31	4.70	0.39	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.83	3.03	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.14	7.62	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	1.40	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.81	3.70	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	6.66	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.57	4.76	1.49	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.59	6.19	1.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.37	13.12	1.25	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	4.58	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.75	6.11	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	3.93	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.30	4.84	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.11	6.80	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.84	8.42	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.04	1.84	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.52	1.41	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	3.51	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.18	3.14	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.55	4.46	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.27	7.11	0.43	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.96	4.50	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.03	3.94	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.96	5.10	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	20.71	17.66	1.53	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	14.55	12.24	1.62	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	20.15	14.51	2.17	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	16.82	9.81	2.02	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	14.15	8.21	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	12.71	12.04	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	25.77	18.88	5.87	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	22.18	15.59	3.07	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	24.63	25.90	2.74	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	12.19	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	20.34	25.76	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	26.93	10.36	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	28.78	27.18	5.86	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	22.51	22.51	5.36	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	17.55	23.16	2.81	3.51
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.81	18.82	6.27	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	21.09	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	15.62	2.47	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	11.61	7.98	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	19.69	10.10	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	58.99	65.05	3.23	4.44
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	39.95	51.13	7.59	5.59
CD34+ Progenitors, donor1	11545-120B6	12.05	11.04	1.00	3.01
CD34+ Progenitors, donor2	11625-122B5	17.98	7.30	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.58	20.67	3.01	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	34.72	31.57	3.61	5.86
CD4+ T Cells, donor1	11225-116C1	24.99	15.35	3.21	0.36
CD4+ T Cells, donor2	11306-117C1	12.86	12.86	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	10.67	6.40	2.44	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	23.99	25.52	3.06	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.99	29.65	7.86	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.40	26.16	4.60	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	17.54	3.32	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	26.69	20.37	3.51	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.38	27.02	4.34	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	24.40	28.30	5.08	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.92	28.21	4.35	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	15.24	4.03	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.22	20.61	2.45	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	27.28	1.76	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.46	35.42	4.22	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.95	29.09	5.40	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.06	28.07	3.01	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	31.00	14.96	1.36	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	31.62	16.61	3.22	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	12.55	8.97	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	23.18	33.93	5.75	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.85	27.73	8.01	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	17.65	22.28	3.99	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.68	17.19	3.54	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.10	17.76	3.47	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	24.41	22.23	3.49	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	34.15	24.74	4.45	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	25.85	18.46	5.54	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	40.48	30.71	4.19	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	30.19	22.71	3.32	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	29.94	23.31	2.45	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	26.18	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	26.14	25.07	2.86	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	23.54	2.77	4.15
CD8+ T Cells, donor1	11226-116C2	18.99	9.82	3.60	0.98
CD8+ T Cells, donor2	11307-117C2	10.89	7.13	1.13	0.38
CD8+ T Cells, donor3	11383-118B6	20.96	8.84	3.53	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.19	15.60	1.38	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.49	14.62	1.20	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.05	16.96	2.19	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.52	21.62	1.80	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.92	9.36	1.68	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.69	17.05	1.36	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.95	17.38	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.06	21.06	2.11	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.23	15.48	1.64	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	33.51	22.04	1.81	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.60	20.04	1.45	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.11	25.58	0.27	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.82	11.82	3.06	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.56	10.47	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	8.20	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.17	14.41	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.14	13.52	1.44	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.21	12.26	0.94	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.25	21.55	1.90	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.37	21.84	0.92	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	18.59	2.89	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	21.04	1.15	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.46	17.73	2.36	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	13.62	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	19.27	15.26	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	16.09	10.49	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	22.04	15.03	3.01	3.01
Cardiac Myocyte, donor1	11525-119I4	7.31	16.45	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	23.22	23.22	3.46	1.48
Cardiac Myocyte, donor3	11686-122I3	22.10	15.78	3.26	1.26
Chondrocyte - de diff, donor1	11261-116G1	42.29	44.37	4.85	3.12
Chondrocyte - de diff, donor2	11338-117F6	14.22	11.73	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	20.94	18.32	3.07	1.37
Chondrocyte - re diff, donor2	11339-117F7	27.75	20.59	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	16.58	10.92	3.24	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	27.77	30.41	2.75	3.10
Ciliary Epithelial Cells, donor2	11323-117D9	24.37	22.45	1.50	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	25.93	21.95	2.57	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.88	11.10	2.38	3.76
Corneal Epithelial Cells, donor1	11526-119I5	3.29	5.71	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	19.34	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.97	10.99	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.02	16.84	2.48	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.50	17.35	4.10	3.15
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	27.61	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.11	18.36	4.64	1.73
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.11	11.27	1.71	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.73	13.06	1.31	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.07	13.55	0.97	5.81
Endothelial Cells - Aortic, donor0	11207-116A1	15.01	8.67	0.33	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	10.56	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	8.77	10.46	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.90	7.86	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	6.40	6.40	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	11.29	12.00	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	15.78	14.02	1.40	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.18	12.19	1.99	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.56	12.17	1.52	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.99	12.40	2.26	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	11.29	12.18	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	18.22	8.33	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.96	5.96	0.99	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	31.61	27.61	2.80	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	6.81	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	31.93	32.80	4.22	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.64	17.38	1.96	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.43	20.15	1.71	0.98
Endothelial Cells - Vein, donor1	11267-116G7	14.79	4.55	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	9.08	3.49	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.27	11.78	1.26	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	1.65	1.65	0.00
Eosinophils, donor3	12246-129H5	0.00	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.53	10.02	2.93	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	14.56	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.76	16.42	3.69	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.93	11.61	2.19	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.13	21.23	2.93	2.06
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.92	21.83	3.40	2.30
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.47	12.15	2.18	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.08	14.98	3.06	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.13	20.55	1.32	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.58	22.92	2.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	19.05	14.97	2.72	0.91
Fibroblast - Cardiac, donor2	11345-117G4	3.79	4.55	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	8.52	10.09	0.79	0.63
Fibroblast - Cardiac, donor4	11452-119A3	16.97	14.55	3.03	1.21
Fibroblast - Cardiac, donor5	11456-119A7	26.52	22.46	2.03	1.52
Fibroblast - Cardiac, donor6	11460-119B2	31.99	29.86	0.76	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.26	10.85	0.80	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.65	13.37	3.02	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	33.69	30.76	4.39	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	17.76	9.23	1.61	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	18.83	13.40	3.39	2.71
Fibroblast - Dermal, donor1	11269-116G9	30.99	26.77	3.76	0.47
Fibroblast - Dermal, donor2	11346-117G5	17.45	11.79	1.89	0.94
Fibroblast - Dermal, donor3	11418-118F5	35.30	24.42	2.54	1.69
Fibroblast - Dermal, donor4	11450-119A1	51.55	38.55	2.83	2.83
Fibroblast - Dermal, donor5	11454-119A5	57.05	41.17	1.57	3.14
Fibroblast - Dermal, donor6	11458-119A9	65.13	45.64	2.44	2.27
Fibroblast - Gingival, donor1	11237-116D4	31.23	24.99	4.16	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.37	22.79	3.67	1.83
Fibroblast - Gingival, donor2	11318-117D4	55.09	33.08	4.74	3.03
Fibroblast - Gingival, donor3	11394-118C8	19.24	15.47	1.84	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	18.70	0.00	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.27	8.81	1.06	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.97	30.40	3.59	4.05
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.40	26.50	2.16	3.11
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1.06	2.12	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	38.61	32.03	3.95	2.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	35.04	35.59	3.68	1.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	39.82	30.82	3.07	3.51
Fibroblast - Gingival, donor9 (control)	11927-125I1	17.76	14.38	2.93	2.05
Fibroblast - Lung, donor1	11270-116H1	6.80	1.36	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	50.73	28.35	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	21.31	11.18	1.06	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	10.00	5.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	5.59	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	3.92	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	25.17	18.27	0.81	2.84
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	56.45	38.99	3.88	4.46
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.63	30.03	2.58	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.64	14.08	0.92	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.33	20.23	3.43	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	21.33	1.08	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.45	10.21	1.86	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.94	23.65	3.54	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.99	13.41	0.20	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.02	9.35	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.86	22.54	2.77	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.82	23.02	1.59	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.74	15.63	1.60	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.76	18.72	1.58	2.17
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.86	24.07	2.71	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.45	19.86	1.51	2.16
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.02	20.75	1.77	1.27
Fibroblast - skin normal, donor1	11553-120C5	22.31	18.87	2.46	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.46	18.45	3.81	0.40
Fibroblast - skin normal, donor2	11561-120D4	23.81	23.41	1.71	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.57	31.43	3.32	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.81	12.84	2.40	1.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.17	28.38	2.39	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	13.79	12.48	0.99	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.60	22.80	1.70	2.45
Fibroblast - skin walker warburg, donor1	11554-120C6	36.27	24.46	2.02	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.98	32.15	4.55	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	310.24	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	14.82	30.50	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.70	22.19	5.20	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.87	25.24	3.90	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.96	16.61	3.07	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	41.34	6.12	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.24	42.75	12.76	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	79.02	90.14	13.12	11.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	55.43	46.33	4.41	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.99	27.63	3.88	7.31
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	71.13	62.21	10.90	6.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	46.52	32.78	8.99	4.23
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	42.07	24.79	2.28	7.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	96.85	100.38	11.06	13.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	43.24	39.57	9.04	4.66
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.18	25.37	5.54	3.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	40.29	35.46	7.79	3.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.06	27.88	4.71	4.21
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	39.31	24.92	4.43	4.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	45.13	34.97	5.90	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.68	23.73	5.25	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.28	22.80	4.86	2.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	32.13	18.36	4.81	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.41	23.05	3.55	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.95	25.75	5.09	3.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.26	21.22	2.90	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	34.08	19.16	3.63	3.43
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.44	35.29	4.41	4.58
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	33.43	30.06	4.70	3.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.39	14.88	2.08	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.69	18.27	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	29.32	25.01	4.32	3.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.95	22.88	3.66	4.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.08	29.61	2.86	3.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.30	16.92	2.48	3.09
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.17	17.64	3.69	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	34.02	26.85	3.17	2.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.23	18.96	3.09	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	37.64	23.86	4.18	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.01	21.88	3.89	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.62	16.68	3.53	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.65	14.69	2.56	2.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.00	21.67	3.32	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	20.68	3.95	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.12	23.10	3.03	2.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.01	22.83	5.05	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.90	21.60	3.09	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.42	21.20	2.41	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.09	36.90	2.94	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.68	25.09	2.14	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.28	27.33	4.66	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	26.29	4.88	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.23	21.02	5.53	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.15	18.42	3.29	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	11.90	11.90	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.56	19.13	3.17	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.80	15.74	3.63	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.42	6.86	1.52	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.20	39.41	9.16	8.56
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	38.98	31.74	7.24	4.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.62	44.39	9.82	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.26	50.38	14.71	6.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	51.14	49.16	13.56	7.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.43	45.66	11.53	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	61.87	9.90	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	58.02	68.85	14.31	9.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	54.55	65.78	14.44	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	57.38	13.91	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	53.38	52.73	13.34	8.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	63.42	57.24	14.41	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	43.32	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	43.90	47.82	11.75	6.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	51.97	41.18	10.79	6.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	37.75	5.03	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	47.71	38.80	8.59	7.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	42.46	39.06	11.89	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	85.61	41.76	8.35	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.01	38.37	6.30	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	32.26	28.12	5.33	4.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	45.74	5.08	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.02	53.85	12.84	11.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.88	46.95	8.98	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	57.95	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.44	38.06	10.38	8.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.66	36.18	6.19	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	68.89	42.81	6.69	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	59.33	26.58	4.62	5.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	54.77	41.42	10.95	7.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	34.79	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	59.92	34.45	5.66	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	28.97	2.41	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	41.71	6.61	5.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.65	37.89	4.79	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	55.75	34.53	7.40	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	56.66	47.22	10.62	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.68	30.34	4.67	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.91	21.07	4.83	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	47.47	28.82	8.48	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.04	27.46	8.95	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	46.58	42.22	5.34	5.34
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	6.85	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.98	7.07	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	4.50	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.76	18.08	1.90	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.46	15.04	3.34	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	63.01	55.70	5.69	3.60
Hep-2 cells mock treated, biol_rep2	11899-125E9	62.46	60.94	5.91	3.88
Hep-2 cells mock treated, biol_rep3	11900-125F1	57.56	58.70	5.46	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	55.42	53.89	7.54	4.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	58.67	58.03	3.87	3.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	52.96	49.73	5.81	3.44
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	55.54	48.94	6.97	2.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	55.07	49.06	5.83	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	49.66	45.81	4.16	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.39	9.51	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	6.06	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	55.52	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	9.52	2.12	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1.45	10.90	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	30.07	33.92	6.29	2.27
Hepatocyte, donor1	11523-119I2	31.48	29.05	9.68	1.21
Hepatocyte, donor2	11603-120I1	21.55	29.09	4.31	0.00
Hepatocyte, donor3	11684-122I1	25.16	28.84	3.68	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	78.32	46.99	3.26	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	33.73	29.71	8.39	3.32
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.62	24.42	3.98	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	4.15	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	12.81	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	4.87	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	11.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	5.29	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	12.20	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.30	13.86	1.26	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	13.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	11.63	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	9.66	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	13.04	0.00	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.82	3.78	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	13.66	0.00	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	7.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	18.41	12.27	0.00	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	17.23	7.26	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	10.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	15.25	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	7.01	0.64	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	9.28	2.14	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	3.32	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.68	12.96	0.00	3.09
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	14.05	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	6.29	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.08	7.65	2.09	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	13.28	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	3.24	6.48	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	2.62	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	4.50	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	10.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	4.27	1.07	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	11.08	1.39	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	11.40	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.26	9.96	1.31	0.41
Keratinocyte - epidermal, donor2	11349-117G8	7.61	4.10	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	33.98	37.67	5.87	0.66
Keratinocyte - oral, donor1	11251-116E9	37.12	37.91	9.31	1.25
Keratocytes, donor1	11527-119I6	22.01	7.91	0.69	1.38
Keratocytes, donor2	11607-120I5	17.58	23.44	1.17	1.17
Keratocytes, donor3	11688-122I5	24.90	13.04	0.99	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	6.59	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	18.34	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	29.18	16.95	3.46	2.54
Lens Epithelial Cells, donor3	11690-122I7	13.93	16.15	3.03	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.01	15.30	2.73	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	8.37	1.40	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.67	23.77	4.09	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.28	20.97	2.15	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.39	11.66	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.37	15.96	1.73	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.65	18.47	2.87	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.08	6.32	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	13.79	14.50	1.97	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	21.36	24.52	2.77	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.87	13.38	1.94	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.78	9.81	0.56	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.47	15.68	2.79	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.03	13.36	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.99	13.32	1.10	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	18.79	1.85	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.91	7.79	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.44	12.08	1.83	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.80	17.77	3.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	9.66	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.96	7.47	1.24	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.85	27.16	3.39	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.89	14.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.95	14.38	1.67	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.59	15.03	2.59	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.01	13.40	1.47	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.98	11.13	1.95	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.88	22.01	2.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	17.12	14.68	2.07	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.09	8.16	1.27	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.99	18.41	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.55	10.59	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.42	9.66	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.88	20.36	2.96	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.82	10.87	2.47	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.62	10.04	0.69	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.73	15.44	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.26	17.04	0.91	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.90	20.30	0.98	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.82	19.20	2.84	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	6.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.78	6.54	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.11	17.19	1.79	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.78	13.07	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.06	5.18	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.97	18.19	2.97	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	5.89	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.35	14.92	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	9.06	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	16.11	2.30	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	22.27	2.23	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	14.81	11.00	2.12	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	14.77	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	16.81	1.87	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	14.43	1.55	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	13.08	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.44	7.92	1.81	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.63	24.72	4.36	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	27.91	2.25	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.17	9.08	1.49	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.89	22.60	2.57	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.11	20.82	6.00	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	17.99	6.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.92	16.30	1.02	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	18.41	23.21	5.60	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	25.70	28.15	3.21	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.79	15.95	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	26.91	25.28	3.26	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	26.45	21.45	5.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.99	30.83	3.92	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	19.58	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.64	22.93	6.97	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	21.52	28.70	2.99	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.04	26.00	6.09	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	19.44	18.38	1.77	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	19.18	2.21	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	16.12	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.03	18.04	3.07	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	16.98	3.40	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	13.95	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	12.20	2.26	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	19.39	24.42	5.03	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	20.91	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.58	17.84	1.86	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.92	18.95	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	20.55	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	19.32	4.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	17.50	15.08	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	12.80	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	13.06	2.41	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	14.49	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	13.47	16.83	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.15	12.59	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	13.96	3.49	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	16.92	11.64	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.81	18.41	3.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.99	12.36	2.91	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	12.26	19.93	6.90	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	21.21	2.96	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	11.29	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	16.09	4.02	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.12	15.32	4.06	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	13.77	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.37	13.36	1.78	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	16.03	1.96	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	14.51	1.98	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.09	11.42	2.08	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	20.13	3.50	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.13	15.10	2.80	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.46	12.37	3.97	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	18.13	1.54	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	18.74	1.52	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	8.65	2.40	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.30	16.30	3.18	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.23	20.05	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	13.14	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.34	17.10	4.18	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.04	14.46	1.55	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	9.67	3.63	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.38	15.85	1.90	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	19.19	15.46	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	15.52	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	20.57	15.43	3.60	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.10	21.93	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	12.48	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.97	13.31	4.16	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.79	11.75	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	15.45	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.66	13.01	1.86	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	13.38	10.04	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	10.16	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.16	16.57	3.23	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	15.60	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	18.67	16.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.79	9.69	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	13.04	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	20.79	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.70	14.70	1.78	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.44	10.92	1.30	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	16.58	17.90	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	10.39	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.06	15.04	2.73	1.37
Macrophage - monocyte derived, donor2	11313-117C8	17.80	15.05	2.02	1.28
Macrophage - monocyte derived, donor3	11389-118C3	21.63	19.14	4.06	1.44
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.65	34.52	5.84	2.12
Mallassez-derived cells, donor2	11929-125I3	18.54	36.76	4.28	0.48
Mallassez-derived cells, donor3	11930-125I4	21.68	49.90	5.84	0.56
Mammary Epithelial Cell, donor1	11273-116H4	39.36	40.06	8.47	1.30
Mammary Epithelial Cell, donor2	11350-117G9	31.56	45.46	5.50	1.16
Mammary Epithelial Cell, donor3	11422-118F9	6.49	8.73	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	23.05	20.34	2.03	0.68
Mast cell, donor1	11563-120D6	17.52	15.25	3.24	1.41
Mast cell, donor2	11565-120D8	8.62	3.27	1.78	0.59
Mast cell, donor3	11566-120D9	10.13	4.50	0.68	1.35
Mast cell, donor4	11567-120E1	7.09	4.43	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	30.83	22.95	2.22	2.44
Mast cell, expanded and stimulated, donor8	11942-126A7	20.43	22.76	2.33	2.33
Mast cell, expanded, donor5	11939-126A4	18.47	14.45	1.38	1.72
Mast cell, expanded, donor8	11941-126A6	12.72	12.89	2.18	2.18
Melanocyte - dark, donor1	11502-119F8	19.50	22.09	3.68	2.59
Melanocyte - dark, donor2	11582-120F7	18.34	22.84	5.19	2.08
Melanocyte - dark, donor3	11663-122F7	26.22	26.08	3.69	1.01
Melanocyte - light, donor1	11274-116H5	5.88	4.47	0.71	0.00
Melanocyte - light, donor2	11351-117H1	5.46	5.46	0.00	0.68
Melanocyte - light, donor3	11423-118G1	5.20	2.60	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	33.63	30.30	4.27	1.35
Melanocyte, donor2 (MC+2)	12739-135I3	16.94	24.47	2.96	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	14.73	22.23	4.02	1.34
Meningeal Cells, donor1	11493-119E8	19.35	17.24	0.74	1.61
Meningeal Cells, donor2	11573-120E7	26.85	16.73	2.20	0.00
Meningeal Cells, donor3	11654-122E7	42.87	29.50	1.96	2.61
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.06	28.80	2.85	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.50	11.87	1.61	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.16	27.99	3.59	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.54	17.36	2.54	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.62	25.63	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.68	15.16	1.10	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.11	21.92	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.89	12.07	1.02	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.81	20.36	0.42	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	3.72	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.42	17.37	2.63	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.37	3.26	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	14.73	0.64	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	39.34	33.32	2.84	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.95	9.07	2.50	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	37.74	5.08	5.08
Mesothelial Cells, donor1	11247-116E5	21.21	16.71	2.39	2.39
Mesothelial Cells, donor2	12156-128G5	15.51	11.01	2.00	1.50
Mesothelial Cells, donor3	11402-118D7	15.46	14.09	1.45	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.73	18.96	3.45	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.31	13.55	2.06	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.40	18.60	1.55	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.20	14.94	2.07	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.27	18.52	3.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.24	8.84	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.48	18.70	2.24	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	8.71	1.19	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	8.85	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	18.62	18.24	1.52	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.37	12.73	1.27	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	6.86	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.55	11.04	3.01	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.37	9.51	1.66	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.20	14.97	1.84	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.04	12.20	0.84	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	13.45	8.97	1.83	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	14.80	14.80	3.86	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.00	7.78	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.76	9.86	1.53	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	6.59	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.79	4.35	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.65	9.70	2.06	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.53	5.29	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.01	8.00	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	6.01	1.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	10.07	2.19	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.90	12.40	1.49	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	4.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.26	14.02	1.71	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.38	3.94	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.71	3.55	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.39	14.03	3.09	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	5.82	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	6.64	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	14.61	3.76	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	8.31	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	14.80	2.85	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.94	7.88	1.38	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.88	12.70	3.37	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	12.44	2.14	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.14	6.94	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.77	24.25	3.59	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.06	7.06	0.71	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.78	17.20	2.23	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.27	20.57	3.76	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	4.55	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.91	18.47	2.56	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.73	22.61	3.44	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	13.82	2.65	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	22.49	2.02	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	9.89	1.24	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	9.83	2.38	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	26.37	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	14.26	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.11	21.03	1.31	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	28.40	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.20	17.99	3.95	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	6.52	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.28	25.16	2.25	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.18	18.91	1.86	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.85	18.10	1.47	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	7.37	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.69	15.76	1.83	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	15.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	32.07	29.93	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	5.05	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	18.55	2.53	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	17.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	17.80	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	17.82	2.43	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	34.74	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	28.55	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	6.52	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	26.93	24.99	1.72	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	24.04	0.52	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	8.01	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	4.17	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	24.34	43.35	2.66	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	11.17	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	2.72	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	58.80	5.51	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	6.28	1.26	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.32	15.81	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.59	7.30	1.35	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.24	14.09	1.26	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	66.81	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	10.42	3.97	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.20	25.71	3.52	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.07	9.97	1.36	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.41	8.65	0.98	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.76	18.41	2.92	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	10.08	3.71	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	5.40	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.78	31.83	4.27	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.85	5.04	0.98	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.82	12.70	1.06	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	9.85	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	2.76	4.14	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	7.71	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.86	34.49	6.21	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	35.40	7.59	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	8.47	1.56	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	5.93	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.49	12.58	2.61	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	7.73	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.66	4.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.76	4.51	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	4.36	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.59	14.76	4.54	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.19	4.89	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.61	4.79	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	15.38	9.05	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	3.53	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	7.31	1.99	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.42	8.93	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	1.53	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.42	15.73	2.12	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.05	14.15	3.54	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	5.42	7.45	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	71.53	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	6.10	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.15	3.78	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.96	3.03	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	3.96	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	21.54	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	75.87	15.17	5.06
Myoblast, donor1	11241-116D8	19.26	22.98	3.85	2.24
Myoblast, donor2	11322-117D8	24.74	25.32	2.11	0.96
Myoblast, donor3	11398-118D3	22.20	17.49	2.86	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	120.39	110.18	17.80	3.79
Natural Killer Cells, donor1	11230-116C6	15.38	11.99	2.77	0.00
Natural Killer Cells, donor2	11311-117C6	11.46	8.14	2.11	1.51
Natural Killer Cells, donor3	11387-118C1	13.80	8.47	1.84	0.18
Neural stem cells, donor1	11275-116H6	21.78	14.15	2.90	3.27
Neural stem cells, donor2	11352-117H2	23.11	26.96	0.00	0.00
Neurons, donor1	11494-119E9	36.41	29.59	5.69	2.28
Neurons, donor2	11574-120E8	31.92	16.73	1.98	4.62
Neurons, donor3	11655-122E8	50.15	32.89	6.58	4.11
Neutrophils, donor1	11233-116C9	3.71	3.71	0.93	0.93
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	3.67	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	16.98	14.49	1.31	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	14.00	13.02	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	23.67	20.86	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	14.59	14.73	2.75	0.14
Olfactory epithelial cells, donor2	11934-125I8	24.61	28.08	4.05	0.43
Olfactory epithelial cells, donor3	11935-125I9	20.09	19.64	4.20	0.34
Olfactory epithelial cells, donor4	11936-126A1	16.36	13.93	1.36	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	24.07	33.10	6.62	1.81
Osteoblast - differentiated, donor1	11276-116H7	12.55	5.10	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	12.57	6.86	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	4.97	4.97	1.24	0.00
Osteoblast, donor1	11277-116H8	8.40	3.71	0.78	0.78
Osteoblast, donor2	11354-117H4	36.52	31.60	2.81	1.40
Osteoblast, donor3	11426-118G4	16.88	10.84	0.71	1.24
Pancreatic stromal cells, donor1	11249-116E7	26.53	22.41	5.56	3.12
Pericytes, donor1	11491-119E6	3.56	1.78	0.11	0.11
Pericytes, donor2	11571-120E5	4.53	7.02	0.68	0.00
Pericytes, donor3	11652-122E5	17.29	13.43	1.22	0.41
Perineurial Cells, donor1	11499-119F5	32.78	24.19	2.83	2.71
Perineurial Cells, donor2	11579-120F4	19.60	21.07	3.13	1.66
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.40	10.52	2.23	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.30	3.43	1.47	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.39	5.95	1.16	0.00
Placental Epithelial Cells, donor1	11278-116H9	13.39	10.04	3.83	0.72
Placental Epithelial Cells, donor2	11355-117H5	8.87	8.87	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.89	4.91	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	14.24	2.53	0.32
Preadipocyte - breast, donor1	11467-119B9	12.94	12.94	3.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.40	12.66	2.48	0.52
Preadipocyte - breast, donor2	11328-117E5	20.94	15.54	3.15	1.35
Preadipocyte - omental, donor1	11468-119C1	17.37	18.75	3.09	0.96
Preadipocyte - omental, donor2	11329-117E6	18.33	15.71	4.36	0.87
Preadipocyte - omental, donor3	11403-118D8	21.20	19.48	3.15	0.86
Preadipocyte - perirenal, donor1	11469-119C2	10.83	6.89	2.95	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	7.99	3.99	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	46.22	40.02	4.60	3.19
Preadipocyte - subcutaneous, donor3	11428-118G6	32.86	29.29	4.94	1.87
Preadipocyte - visceral, donor1	11280-116I2	43.50	37.91	3.82	3.26
Preadipocyte - visceral, donor2	11357-117H7	26.69	29.91	2.30	1.84
Preadipocyte - visceral, donor3	11429-118G7	43.36	35.11	3.66	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	29.87	22.48	5.58	3.32
Prostate Epithelial Cells, donor2	11331-117E8	9.61	17.47	2.44	0.81
Prostate Epithelial Cells, donor3	11404-118D9	29.21	27.68	6.55	1.41
Prostate Stromal Cells, donor1	11254-116F3	23.69	23.01	3.19	2.96
Prostate Stromal Cells, donor2	11332-117E9	33.71	26.89	3.41	4.12
Prostate Stromal Cells, donor3	11405-118E1	19.19	17.10	3.02	1.88
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.30	6.20	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.45	23.22	1.52	1.39
Renal Epithelial Cells, donor1	11517-119H5	4.06	3.04	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.11	4.98	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	34.41	26.04	2.12	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	6.81	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.17	17.92	0.81	1.48
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.53	30.86	2.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	3.99	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	10.56	7.48	0.44	0.44
Renal Mesangial Cells, donor2	11598-120H5	11.91	10.03	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.94	4.44	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.65	19.33	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.13	11.39	1.69	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.08	10.22	0.58	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.52	22.30	2.33	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.80	9.10	0.57	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	10.29	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	12.29	1.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.65	17.37	2.27	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	62.54	7.15	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	52.84	121.08	17.61	14.86
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	32.48	64.39	6.96	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.24	62.28	6.50	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	45.38	55.71	8.24	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.11	70.72	8.92	14.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.38	117.22	18.11	10.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	60.02	72.26	8.62	7.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	66.80	89.22	11.33	8.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	45.59	71.47	9.17	8.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.26	62.32	8.77	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.58	57.70	8.96	11.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	53.22	82.63	10.33	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	53.44	65.46	10.73	6.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.41	72.58	12.83	10.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	49.13	75.32	6.12	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.28	56.36	7.73	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	67.83	77.23	12.40	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.03	66.49	8.36	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.01	54.12	7.40	6.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	63.59	84.40	10.31	8.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	47.42	73.58	6.62	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.68	56.62	8.13	7.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.76	62.21	9.40	6.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.92	71.84	7.66	4.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	47.46	55.31	8.58	8.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	54.67	64.47	8.87	8.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.94	105.20	9.20	11.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	51.98	60.71	8.93	8.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	65.94	84.65	11.93	7.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	61.79	92.90	12.86	9.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	61.72	71.01	6.64	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.46	59.11	9.82	6.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.97	79.14	8.61	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.72	56.71	6.13	7.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	52.63	64.01	11.37	8.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.21	105.91	12.04	8.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.29	51.44	6.72	5.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.03	73.06	10.51	11.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	52.15	80.27	8.69	5.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.17	68.36	13.76	9.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	37.32	65.04	8.80	7.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	26.41	52.40	5.81	6.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	46.19	51.43	7.86	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	46.35	63.69	11.29	5.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.97	63.94	7.53	6.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.44	54.85	7.69	8.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.18	42.31	8.46	6.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.00	68.41	8.81	7.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	59.97	95.92	19.07	12.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.76	62.06	13.99	7.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.11	90.42	9.95	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.75	39.81	6.11	8.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.65	49.72	12.28	8.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.44	40.03	6.38	10.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	25.61	31.16	5.12	8.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.66	72.12	16.23	9.01
Schwann Cells, donor1	11498-119F4	8.09	7.52	0.38	0.75
Schwann Cells, donor2	11578-120F3	20.41	20.41	0.00	0.00
Schwann Cells, donor3	11659-122F3	26.95	23.66	3.07	1.75
Sebocyte, donor1	11220-116B5	14.24	15.34	2.19	1.10
Sebocyte, donor2	11301-117B5	11.49	15.17	5.06	0.00
Sebocyte, donor3	11378-118B1	11.13	10.72	2.47	0.62
Sertoli Cells, donor1	11255-116F4	29.82	18.22	8.28	0.00
Sertoli Cells, donor2	11333-117F1	11.30	25.42	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.84	9.15	0.79	1.23
Skeletal Muscle Cells, donor2	11358-117H8	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	5.85	0.00	3.34
Skeletal Muscle Cells, donor4	11451-119A2	57.50	44.61	2.36	2.98
Skeletal Muscle Cells, donor5	11455-119A6	50.54	40.58	2.38	2.08
Skeletal Muscle Cells, donor6	11459-119B1	67.26	39.71	2.77	3.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.27	30.62	4.66	2.14
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.39	23.40	2.85	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.19	33.14	2.78	2.68
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.56	8.76	1.35	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	7.24	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.81	8.67	0.55	0.69
Skin - palm, donor1	10286-104F7	5.37	8.06	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.08	13.98	2.02	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	49.07	4.09	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	17.14	1.56	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	23.49	34.61	7.09	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	17.44	3.94	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.36	37.00	6.98	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	14.32	19.34	3.97	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.53	25.30	1.85	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.89	17.12	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	15.28	1.18	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.18	7.51	1.10	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	5.91	1.58	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	13.13	0.00	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	18.01	4.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.12	5.59	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	28.15	22.83	3.32	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	20.61	17.80	1.54	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.44	22.47	1.95	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.74	17.42	2.95	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	15.80	1.28	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.95	7.65	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	11.26	8.22	0.91	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.62	4.55	1.52	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.11	1.91	0.95	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.40	20.94	2.21	2.36
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.54	27.34	3.23	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	32.43	27.60	2.94	3.04
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.58	3.71	0.93	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	11.86	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.24	12.25	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.19	3.76	0.34	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.78	21.20	3.85	1.49
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.83	15.20	0.81	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.48	27.31	3.41	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	7.25	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.47	49.81	5.30	4.24
Smooth Muscle Cells - Prostate, donor1	11257-116F6	28.90	32.49	2.93	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.04	18.66	2.50	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.43	10.91	1.27	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	27.59	19.45	2.26	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	8.25	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	6.51	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	10.10	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.72	10.03	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.55	7.96	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	45.57	31.66	3.08	3.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	17.75	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.26	8.06	1.15	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.06	15.30	0.51	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.60	11.28	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.71	27.39	3.21	3.21
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.72	17.93	2.60	1.51
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.95	9.54	1.22	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.28	25.85	2.21	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.04	26.33	5.27	3.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.33	17.88	2.14	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.36	32.79	3.70	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	33.48	43.52	5.21	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.84	31.26	2.87	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.19	22.71	2.56	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	47.26	47.66	4.33	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	23.36	33.78	4.32	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	15.97	21.56	1.60	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	36.78	2.93	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	22.00	0.92	1.38
Synoviocyte, donor1	11291-117A4	23.90	17.84	2.19	1.35
Synoviocyte, donor2	11368-117I9	17.27	18.94	4.69	1.17
Synoviocyte, donor3	11440-118H9	19.44	21.00	3.13	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	22.51	17.87	2.50	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	9.91	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.88	5.56	1.16	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	28.10	27.60	4.80	1.00
Tracheal Epithelial Cells, donor2	11369-118A1	10.44	5.80	1.16	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	7.44	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	26.45	14.89	2.83	0.98
Urethra, donor2	10319-105A4	19.78	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.91	10.89	1.86	0.00
Urothelial Cells, donor2	11600-120H7	5.21	8.41	2.00	0.00
Urothelial Cells, donor3	11681-122H7	3.67	5.04	1.15	0.46
Urothelial cells, donor0	11216-116B1	22.07	16.94	4.24	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	11.57	15.13	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	17.16	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	7.53	6.16	4.11	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	14.81	14.46	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	11.04	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	7.29	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	18.36	20.19	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	5.48	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	52.31	43.92	6.04	3.45
Wilms' tumor cell line:HFWT	10597-108E3	15.84	4.40	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	176.53	53.07	3.63	1.40
achilles tendon, donor2	10292-104G4	4.13	10.33	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.21	61.95	10.20	5.10
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	68.96	37.61	3.48	4.88
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.35	21.96	2.73	5.58
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	52.25	41.09	5.17	22.86
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	172.59	129.02	8.43	9.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	28.76	37.22	10.15	3.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.59	33.48	2.72	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	41.86	34.37	2.20	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	36.75	25.73	2.04	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	74.55	51.26	5.05	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	33.30	33.30	2.58	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	42.91	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	69.25	72.27	6.74	7.90
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	86.21	80.00	7.25	6.47
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	62.25	60.20	3.51	3.51
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	29.74	34.86	2.79	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	52.64	48.94	2.88	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.22	8.29	1.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.01	55.90	5.97	8.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	55.81	25.48	2.43	6.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	61.14	31.77	2.89	9.87
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	79.07	78.63	8.46	4.01
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	39.02	30.69	1.00	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	89.19	50.17	11.15	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	91.91	73.07	9.04	5.65
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	24.86	17.88	3.05	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	28.12	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	65.00	72.30	6.59	0.94
adipose tissue, adult, pool1	10010-101C1	14.43	8.84	1.09	1.09
adipose, donor1	10184-103D4	73.30	104.38	14.66	15.25
adipose, donor2	10185-103D5	23.11	13.38	0.81	4.46
adipose, donor3	10186-103D6	36.21	30.50	5.99	4.08
adipose, donor4	10187-103D7	42.47	42.47	4.33	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	42.93	14.68	1.58	2.21
adrenal gland, adult, pool1	10081-102A9	14.55	10.91	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.21	19.21	5.60	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.88	45.73	2.50	2.86
amniotic membrane cells, donor1	12235-129G3	16.00	9.27	5.10	0.00
amniotic membrane cells, donor2	12236-129G4	25.36	10.14	3.72	0.68
amniotic membrane cells, donor3	12237-129G5	13.55	12.08	2.36	0.59
amygdala - adult, donor10196	10167-103B5	33.20	26.09	4.74	0.00
amygdala, adult, donor10252	10151-102I7	24.53	14.80	3.24	0.41
amygdala, newborn, donor10223	10360-105E9	11.30	9.68	0.32	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	26.23	11.08	1.91	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	76.78	58.24	5.74	2.43
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.41	27.39	5.34	2.34
aorta, adult, pool1	10052-101G7	15.10	6.28	1.37	0.00
appendix, adult	10189-103D9	15.52	13.97	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	133.10	144.45	15.82	3.44
artery, adult	10190-103E1	20.38	12.23	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	100.25	63.16	10.00	7.24
b cell line:RPMI1788	10427-106D4	43.12	22.90	2.38	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.98	13.87	1.66	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	44.95	22.03	1.39	1.79
bile duct carcinoma cell line:TFK-1	10496-107C1	26.28	13.56	1.00	2.68
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	41.38	22.37	4.47	1.68
bladder, adult, pool1	10011-101C2	15.64	6.08	0.76	0.76
blood, adult, pool1	10053-101G8	17.72	8.86	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.13	17.98	1.71	0.00
bone marrow, adult	10192-103E3	28.34	20.24	2.70	0.00
brain, adult, donor1	10084-102B3	13.33	2.05	2.05	1.03
brain, adult, pool1	10012-101C3	18.26	8.02	1.67	0.22
brain, fetal, pool1	10085-102B4	13.36	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	24.12	23.13	3.63	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	22.84	24.96	4.74	1.00
breast, adult, donor1	10080-102A8	10.73	5.68	1.89	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	75.71	54.25	3.18	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	46.07	60.61	6.49	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	104.29	39.60	3.45	8.29
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	71.42	51.56	4.84	1.45
carcinoid cell line:NCI-H1770	10703-109H1	37.14	22.57	2.35	4.23
carcinoid cell line:NCI-H727	10735-110B6	40.80	16.84	1.75	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	48.17	36.44	6.65	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.33	19.43	1.86	2.40
caudate nucleus - adult, donor10196	10177-103C6	17.27	17.27	6.91	2.30
caudate nucleus, adult, donor10252	10164-103B2	23.93	16.57	3.68	0.50
caudate nucleus, adult, donor10258	10379-105H1	24.45	19.10	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	23.07	13.18	1.46	2.56
cerebellum - adult, donor10196	10173-103C2	43.70	20.39	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	32.67	16.01	2.56	1.49
cerebellum, adult, pool1	10083-102B2	21.73	7.93	1.38	0.34
cerebellum, newborn, donor10223	10357-105E6	26.57	15.78	4.98	3.32
cerebral meninges, adult	10188-103D8	11.09	10.34	1.26	1.01
cerebrospinal fluid, donor2	10294-104G6	13.89	8.77	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	27.03	26.02	6.61	0.29
cervical cancer cell line:ME-180	10553-107I4	46.90	51.70	21.21	4.47
cervix, adult, pool1	10013-101C4	13.75	8.08	1.78	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.72	20.76	3.90	3.62
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	34.80	33.31	3.73	3.60
choriocarcinoma cell line:SCH	10785-110H2	63.58	28.59	3.57	3.45
choriocarcinoma cell line:T3M-3	10618-108G6	14.23	11.15	0.95	1.19
chorionic membrane cells, donor1	12238-129G6	16.24	11.97	2.85	0.00
chorionic membrane cells, donor2	12239-129G7	22.57	17.00	2.68	1.39
chorionic membrane cells, donor3	12240-129G8	18.68	14.84	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	76.74	68.67	4.04	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	103.93	113.15	14.22	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	52.80	66.52	7.18	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	61.89	40.32	4.11	4.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.50	48.38	3.14	5.56
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	57.21	40.52	3.05	4.07
chronic myelogenous leukemia cell line:K562	10454-106G4	95.99	58.01	4.71	6.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	49.26	68.28	7.82	4.95
clear cell carcinoma cell line:JHOC-5	10638-108I8	83.66	68.57	5.71	2.51
clear cell carcinoma cell line:TEN	10636-108I6	31.40	20.30	4.16	2.08
colon carcinoma cell line:CACO-2	10513-107D9	44.85	34.78	4.21	5.31
colon carcinoma cell line:COLO-320	10420-106C6	52.45	44.47	5.70	4.56
colon, adult, donor1	10082-102B1	15.47	29.75	8.33	1.19
colon, adult, pool1	10014-101C5	16.10	15.28	2.12	0.94
colon, fetal, donor1	10070-101I7	19.78	19.78	8.03	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	52.27	29.75	4.25	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.30	38.34	2.11	1.96
cord blood derived cell line:COBL-a untreated	10449-106F8	51.61	39.06	2.54	3.53
corpus callosum, adult, pool1	10042-101F6	18.02	4.42	1.11	0.88
cruciate ligament, donor2	10295-104G7	19.45	9.73	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	31.30	13.64	0.80	0.80
diencephalon, adult	10193-103E4	19.68	9.36	1.44	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	49.37	52.81	4.59	2.30
ductal cell carcinoma cell line:KLM-1	10438-106E6	45.65	33.59	2.56	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.92	23.11	3.37	0.96
ductus deferens, adult	10196-103E7	21.93	19.93	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	21.60	5.76	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	28.69	32.37	2.94	3.68
dura mater, adult, donor1	10041-101F5	21.89	7.76	0.83	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.08	48.19	9.10	10.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	68.21	51.44	5.45	14.33
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	16.65	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	44.20	16.35	0.91	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.05	20.07	1.54	2.16
embryonic pancreas cell line:2C6	10603-108E9	55.17	24.96	5.25	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	43.24	24.47	2.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.07	17.58	2.72	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.29	48.08	5.79	1.77
epidermoid carcinoma cell line:A431	10426-106D3	44.24	35.57	3.67	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.55	45.31	5.72	5.17
epididymis, adult	10197-103E8	17.37	11.51	1.05	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	29.98	10.64	0.89	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.45	14.16	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	105.23	74.57	11.27	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	80.02	59.94	7.78	5.91
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	106.88	69.79	8.96	4.71
esophagus, adult, pool1	10015-101C6	17.63	17.73	1.70	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	21.92	9.89	0.88	1.50
eye - muscle inferior rectus, donor1	10272-104E2	24.15	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	6.31	4.21	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	11.66	0.00	0.00
eye, fetal, donor1	10054-101G9	26.69	9.15	2.29	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	40.26	22.31	2.05	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.06	31.34	2.61	1.90
frontal lobe, adult, pool1	10040-101F4	22.99	10.41	2.44	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	60.95	47.44	12.31	4.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	26.61	11.80	0.46	1.37
gall bladder, adult	10198-103E9	12.07	12.07	2.17	0.72
gamma delta positive T cells, donor1	11937-126A2	23.08	13.96	6.98	1.07
gamma delta positive T cells, donor2	11938-126A3	21.66	16.06	2.61	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.15	23.87	3.17	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	40.42	33.65	4.26	1.93
gastric cancer cell line:AZ521	10549-107H9	44.10	21.15	1.48	4.92
gastric cancer cell line:GSS	10560-108A2	55.83	34.78	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	72.19	37.01	4.11	5.71
giant cell carcinoma cell line:LU65	10487-107B1	39.93	29.26	3.33	2.98
giant cell carcinoma cell line:Lu99B	10433-106E1	49.69	32.33	2.94	2.80
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.44	30.93	7.73	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.58	12.88	1.16	1.48
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.08	13.34	1.26	0.70
glioblastoma cell line:T98G	10485-107A8	49.78	27.37	2.54	3.31
glioma cell line:GI-1	10413-106B8	33.39	25.77	4.10	2.64
globus pallidus - adult, donor10196	10175-103C4	21.14	17.49	2.92	0.73
globus pallidus, adult, donor10252	10161-103A8	31.98	10.01	2.69	0.49
globus pallidus, adult, donor10258	10367-105F7	31.49	13.69	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	23.98	10.66	4.26	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	32.79	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.56	8.96	1.28	1.28
hIPS +CCl2, biol_rep1	14383-156B9	82.64	80.35	7.80	5.51
hIPS +CCl2, biol_rep2	14384-156C1	58.07	76.36	8.23	2.29
hIPS +CCl2, biol_rep3	14385-156C2	72.78	83.09	5.80	1.29
hIPS, biol_rep1	14380-156B6	64.68	148.04	5.75	0.00
hIPS, biol_rep2	14381-156B7	58.98	67.22	2.74	2.74
hIPS, biol_rep3	14382-156B8	28.69	30.90	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	35.34	29.88	3.16	2.01
heart - mitral valve, adult	10205-103F7	19.43	12.26	0.60	1.20
heart - pulmonic valve, adult	10206-103F8	31.64	13.07	1.83	1.05
heart - tricuspid valve, adult	10207-103F9	12.49	11.66	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	34.28	19.39	4.49	2.65
heart, adult, diseased, donor1	10051-101G6	37.90	15.33	3.41	0.00
heart, adult, pool1	10016-101C7	23.92	8.97	1.38	0.92
heart, fetal, pool1	10046-101G1	27.52	12.83	2.46	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.92	11.42	2.47	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	17.84	5.95	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	54.58	60.66	12.93	4.75
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.10	63.24	13.47	4.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	59.32	67.60	16.27	5.66
hepatoma cell line:Li-7	10484-107A7	63.39	32.92	4.00	4.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	70.55	71.66	7.54	2.81
hippocampus - adult, donor10196	10169-103B7	22.71	21.77	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	26.12	12.25	4.90	1.02
hippocampus, adult, donor10258	10374-105G5	18.92	25.40	1.99	0.50
hippocampus, newborn, donor10223	10363-105F3	11.63	10.57	1.41	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.67	117.80	18.92	23.80
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	47.91	38.49	9.23	6.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	60.68	43.92	8.63	10.66
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.27	31.58	6.77	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.73	30.73	9.04	7.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.96	37.58	6.07	9.11
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.28	27.74	1.46	8.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.19	25.21	2.59	9.69
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.20	29.61	2.92	12.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	40.02	30.55	6.39	11.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.20	29.25	7.07	9.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	44.44	35.01	5.39	18.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	54.14	42.41	7.67	10.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	71.24	60.43	8.84	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	96.00	97.75	11.35	20.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.13	34.36	5.73	6.68
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.09	29.65	4.80	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	55.47	11.49	10.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.80	13.75	2.64	4.90
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	26.83	22.74	2.27	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.26	24.75	3.45	5.95
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	35.44	31.03	8.33	6.04
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	45.58	27.87	4.94	6.97
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	31.98	32.88	5.68	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	56.16	41.38	10.35	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	56.77	35.38	7.70	7.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	69.41	73.90	12.25	7.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	37.32	38.02	6.69	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	34.84	21.86	5.70	6.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	38.43	34.50	2.12	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	15.51	2.59	6.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.90	15.94	1.33	7.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.14	21.29	3.08	10.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.68	26.84	4.35	6.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	34.83	25.75	2.27	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.97	31.59	3.36	7.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	58.93	41.54	7.73	4.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	65.96	57.94	7.58	11.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	75.61	42.93	10.24	7.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.64	29.34	3.67	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	165.92	289.54	52.05	35.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.33	48.65	5.63	8.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.93	19.16	2.19	14.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.95	19.90	3.26	7.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.54	16.73	1.07	9.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	22.67	1.19	9.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.10	22.35	4.20	10.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	39.87	26.40	3.23	6.47
immature langerhans cells, donor1	11904-125F5	10.41	13.08	1.94	0.73
immature langerhans cells, donor2	11905-125F6	2.38	8.71	3.17	0.00
insula, adult, pool1	10039-101F3	19.59	11.55	1.89	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	70.88	103.40	15.28	4.23
kidney, adult, pool1	10017-101C8	29.94	25.23	4.51	1.90
kidney, fetal, pool1	10045-101F9	14.15	8.56	0.92	1.63
large cell lung carcinoma cell line:IA-LM	10509-107D5	50.84	32.81	3.83	3.55
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.83	10.92	1.38	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.56	11.93	1.83	1.28
left atrium, adult, donor1	10079-102A7	22.34	18.52	2.72	0.54
left ventricle, adult, donor1	10078-102A6	29.33	15.68	4.55	0.00
leiomyoblastoma cell line:G-402	10721-110A1	28.18	17.51	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	21.91	17.96	1.80	1.08
leiomyoma cell line:15242A	10570-108B3	15.22	17.93	1.09	0.54
leiomyoma cell line:15425	10571-108B4	26.95	20.40	2.19	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	29.28	7.32	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	70.01	129.75	25.38	1.65
liposarcoma cell line:KMLS-1	10782-110G8	31.71	24.37	3.59	1.56
liposarcoma cell line:SW 872	10726-110A6	51.05	20.96	2.80	2.31
liver, adult, pool1	10018-101C9	24.80	18.96	2.76	0.65
liver, fetal, pool1	10086-102B5	25.40	12.23	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	18.81	12.40	4.37	1.17
locus coeruleus, adult, donor10252	10165-103B3	25.47	15.13	2.77	1.29
locus coeruleus, adult, donor10258	10375-105G6	16.08	10.72	2.54	0.56
locus coeruleus, newborn, donor10223	10362-105F2	27.76	19.77	4.21	2.10
lung adenocarcinoma cell line:A549	10499-107C4	24.36	15.22	2.77	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	11.03	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	35.46	15.29	1.98	1.05
lung, adult, pool1	10019-101D1	11.34	7.44	1.65	0.35
lung, fetal, donor1	10068-101I5	27.68	16.55	0.57	2.57
lung, right lower lobe, adult, donor1	10075-102A3	16.04	14.66	4.12	0.46
lymph node, adult, donor1	10077-102A5	17.04	10.89	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	29.15	21.92	1.97	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	29.58	46.94	10.72	2.57
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	37.38	6.80	2.55
mature adipocyte, donor1	12231-129F8	12.43	4.88	1.33	2.66
mature adipocyte, donor2	12232-129F9	13.90	9.34	0.83	1.66
mature adipocyte, donor3	12233-129G1	12.33	5.69	0.71	0.95
mature adipocyte, donor4	12234-129G2	13.95	8.16	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	36.69	22.40	3.81	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	28.20	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.40	13.06	2.21	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	26.69	19.06	3.18	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	23.88	5.97	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	31.05	19.07	4.39	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	25.47	12.52	2.55	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	44.30	3.85	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.64	10.77	2.15	1.08
medulla oblongata - adult, donor10196	10174-103C3	39.59	24.01	0.65	1.95
medulla oblongata, adult, donor10252	10155-103A2	26.47	11.92	2.48	0.93
medulla oblongata, adult, pool1	10038-101F2	17.47	7.67	0.57	1.06
medulla oblongata, newborn, donor10223	10361-105F1	23.61	9.03	2.43	1.04
medulloblastoma cell line:D283 Med	10838-111E1	43.18	39.41	6.64	2.88
medulloblastoma cell line:ONS-76	10759-110E3	50.62	39.25	4.28	2.20
melanoma cell line:COLO 679	10514-107E1	16.39	21.27	3.88	1.01
melanoma cell line:G-361	10465-106H6	26.33	17.65	2.17	1.36
meningioma cell line:HKBMM	10691-109F7	29.67	17.55	2.71	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	31.72	4.41	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	43.81	31.11	3.89	7.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.90	43.11	4.91	2.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.36	24.00	3.27	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.40	43.89	4.56	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.68	21.07	3.23	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	25.03	3.08	3.27
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	14.58	31.93	4.16	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	20.25	13.56	4.63	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.86	16.79	2.07	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.16	36.21	3.58	2.39
mesenchymal precursor cell - cardiac, donor4	11755-123G9	31.60	34.98	4.59	2.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.34	28.74	4.55	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.17	11.53	0.33	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	25.74	26.29	3.74	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.64	21.29	2.09	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.72	23.48	2.04	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	8.63	1.80	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.24	13.14	0.83	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.86	10.49	2.28	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.24	42.38	5.87	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.63	25.85	3.29	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.17	18.56	2.19	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.25	15.09	2.58	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.02	10.59	0.86	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.94	43.79	4.63	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.29	21.01	5.02	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	20.97	21.49	2.56	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.06	28.27	2.36	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	17.25	20.33	2.77	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.71	24.24	4.00	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.74	24.03	4.40	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.43	23.58	1.57	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.85	19.93	2.78	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	23.36	26.53	5.77	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.20	24.09	3.79	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.75	25.24	4.57	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	24.20	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.46	29.20	4.36	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	25.38	4.09	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.76	24.06	4.30	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	21.88	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	15.49	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.93	27.61	4.55	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	26.19	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.26	22.39	2.13	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.08	25.35	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.32	23.71	2.33	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	31.48	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	18.88	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	42.90	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	27.28	22.53	5.93	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	15.84	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.63	18.37	4.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	20.00	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	19.34	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	15.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	20.66	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.45	15.89	2.44	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	13.51	15.09	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	11.20	2.36	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.27	18.39	2.18	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	13.37	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	13.01	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	28.25	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	18.59	3.44	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	22.27	4.95	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	11.22	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	17.81	3.18	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	33.45	21.36	1.21	2.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	26.17	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	15.20	5.07	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.17	21.24	3.03	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	49.71	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	15.65	5.77	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.83	18.26	2.98	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.07	18.50	5.19	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	15.28	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	4.64	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.97	19.37	1.65	3.78
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.35	15.99	1.39	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	21.37	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	46.65	44.80	6.47	2.36
mesothelioma cell line:Mero-25	10850-111F4	20.43	21.33	1.82	1.13
mesothelioma cell line:Mero-41	10851-111F5	38.38	22.98	1.22	2.69
mesothelioma cell line:Mero-48a	10852-111F6	30.11	34.32	4.21	0.44
mesothelioma cell line:Mero-82	10853-111F7	48.88	52.56	8.15	1.05
mesothelioma cell line:Mero-83	10854-111F8	30.47	27.75	4.77	1.53
mesothelioma cell line:Mero-84	10855-111F9	35.89	19.21	2.27	2.53
mesothelioma cell line:Mero-95	10856-111G1	36.03	35.40	5.18	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	71.23	47.21	2.98	4.97
mesothelioma cell line:NCI-H226	10846-111E9	40.18	36.38	5.25	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	39.12	30.06	2.22	1.20
mesothelioma cell line:NCI-H28	10845-111E8	37.92	43.26	4.58	2.29
mesothelioma cell line:No36	10857-111G2	70.13	44.69	1.96	3.26
mesothelioma cell line:ONE58	10858-111G3	40.64	29.53	1.63	0.54
migratory langerhans cells, donor1	11901-125F2	20.15	18.23	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	15.02	12.46	1.22	0.37
migratory langerhans cells, donor3	11903-125F4	20.64	24.77	2.15	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	61.38	34.93	5.88	4.57
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	48.32	54.04	9.75	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.03	20.73	2.99	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.25	45.48	5.52	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	133.05	98.86	13.67	16.63
myeloma cell line:PCM6	10474-106I6	21.35	17.39	4.15	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.83	10.65	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	53.55	45.11	5.30	5.49
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.21	31.64	5.13	1.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.98	36.84	7.72	2.21
nasal epithelial cells, donor2	12227-129F4	27.60	22.08	5.52	1.10
neuroblastoma cell line:CHP-134	10508-107D4	36.58	14.95	3.68	4.14
neuroblastoma cell line:NB-1	10539-107G8	33.30	26.38	5.24	3.74
neuroblastoma cell line:NBsusSR	10607-108F4	65.80	40.28	4.43	5.90
neuroblastoma cell line:NH-12	10555-107I6	34.85	17.14	2.24	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.74	8.30	0.47	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.79	29.30	3.80	3.64
neuroectodermal tumor cell line:TASK1	10774-110F9	28.38	17.51	1.61	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	43.87	17.17	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	18.63	21.29	2.13	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	70.52	25.71	6.60	3.72
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	130.48	88.06	15.21	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.34	25.01	1.92	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	25.49	18.92	3.68	2.63
nucleus accumbens, adult, pool1	10037-101F1	20.72	9.00	1.69	0.94
occipital cortex - adult, donor10196	10172-103C1	35.03	24.72	16.48	0.00
occipital cortex, adult, donor10252	10163-103B1	23.62	15.83	1.88	0.54
occipital cortex, newborn, donor10223	10355-105E4	14.19	11.28	1.46	0.73
occipital lobe, adult, donor1	10076-102A4	21.78	14.69	1.05	1.05
occipital lobe, fetal, donor1	10073-102A1	35.62	13.30	3.00	3.00
occipital pole, adult, pool1	10036-101E9	11.20	3.47	0.87	0.71
olfactory region, adult	10195-103E6	19.30	10.13	1.72	0.00
optic nerve, donor1	10277-104E7	8.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.32	35.88	7.29	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	86.97	53.72	5.50	4.95
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	37.76	32.00	2.88	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	56.95	73.93	6.24	2.43
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	13.23	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	38.31	4.67	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	344.81	212.48	37.96	29.69
ovary, adult, pool1	10020-101D2	15.37	4.89	0.79	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.11	19.43	3.48	0.00
pancreas, adult, donor1	10049-101G4	22.58	15.05	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.34	43.61	4.47	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	62.86	46.00	4.94	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	21.36	13.41	0.83	1.99
paracentral gyrus, adult, pool1	10035-101E8	16.02	10.34	1.92	1.37
parietal cortex, adult, donor10258	10373-105G4	26.42	13.95	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	26.33	19.75	4.70	0.00
parietal lobe, adult, donor10252	10157-103A4	28.50	13.40	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	16.92	8.28	1.50	0.79
parietal lobe, fetal, donor1	10072-101I9	34.91	15.52	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	14.95	9.35	2.24	2.99
parotid gland, adult	10199-103F1	14.80	12.33	1.23	0.00
penis, adult	10200-103F2	20.95	11.28	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	47.97	11.71	0.93	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	70.22	42.25	3.35	1.31
pineal gland - adult, donor10196	10179-103C8	24.51	20.00	5.81	1.29
pineal gland, adult, donor10252	10160-103A7	43.23	23.69	2.96	5.33
pineal gland, adult, donor10258	10377-105G8	35.74	35.12	4.39	0.00
pituitary gland - adult, donor10196	10180-103C9	28.33	30.35	5.06	0.00
pituitary gland, adult, donor10252	10162-103A9	41.69	27.62	3.65	3.13
pituitary gland, adult, donor10258	10378-105G9	28.94	27.24	5.96	1.70
placenta, adult, pool1	10021-101D3	16.66	8.82	2.15	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	58.14	45.82	5.16	4.50
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.65	5.60	1.09	0.47
pons, adult, pool1	10033-101E6	20.83	11.88	2.07	0.69
postcentral gyrus, adult, pool1	10032-101E5	14.65	7.06	1.83	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	22.03	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	56.81	23.01	2.91	9.32
prostate cancer cell line:PC-3	10439-106E7	132.86	91.30	6.72	6.35
prostate, adult, pool1	10022-101D4	16.05	6.35	1.36	1.45
putamen, adult, donor10196	10176-103C5	23.61	14.16	4.72	0.94
putamen, adult, donor10252	10152-102I8	15.69	9.80	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	37.16	56.83	5.46	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	17.64	18.36	2.17	1.69
putamen, newborn, donor10223	10365-105F5	45.73	19.49	5.25	5.25
rectal cancer cell line:TT1TKB	10469-106I1	21.53	17.75	3.49	0.87
rectum, fetal, donor1	10067-101I4	29.21	25.04	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.44	11.87	0.85	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	16.57	4.14	0.00
retina, adult, pool1	10030-101E3	16.80	5.77	1.79	0.40
retinoblastoma cell line:Y79	10475-106I7	40.53	44.17	8.83	4.94
rhabdomyosarcoma cell line:KYM-1	10787-110H4	43.03	35.29	2.83	2.21
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	76.77	26.71	3.37	11.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	11.37	1.52	0.00
salivary acinar cells, donor1	11771-123I7	14.24	24.28	4.86	1.62
salivary acinar cells, donor2	11772-123I8	17.49	21.48	3.44	1.10
salivary acinar cells, donor3	11773-123I9	5.96	9.93	1.99	0.00
salivary gland, adult, pool1	10093-102C3	24.59	21.16	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	17.45	13.32	1.69	3.79
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	24.45	18.57	1.65	4.11
seminal vesicle, adult	10201-103F3	21.16	12.17	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	33.77	39.84	7.77	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.41	23.40	1.51	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	52.18	48.17	4.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.70	36.54	5.51	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	36.81	31.28	3.32	3.09
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.55	30.71	5.03	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	7.09	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	17.87	6.12	0.96	0.84
skeletal muscle, fetal, donor1	10066-101I3	12.06	8.04	1.01	3.02
skin, adult, donor1	10074-102A2	13.57	33.93	6.79	6.79
skin, fetal, donor1	10065-101I2	24.62	21.46	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.36	28.35	2.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	74.70	55.16	11.03	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.06	23.32	1.35	6.75
small cell lung carcinoma cell line:LK-2	10541-107H1	75.00	55.71	11.21	4.78
small cell lung carcinoma cell line:NCI-H82	10842-111E5	49.70	17.37	2.09	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.10	32.91	6.54	2.40
small intestine, adult, pool1	10024-101D6	18.99	21.50	3.11	1.19
small intestine, fetal, donor1	10064-101I1	30.71	33.66	5.90	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	30.77	22.05	2.05	0.51
smooth muscle, adult, pool1	10048-101G3	16.80	5.94	1.29	0.78
somatostatinoma cell line:QGP-1	10781-110G7	17.69	19.03	2.14	0.27
spinal cord - adult, donor10196	10181-103D1	21.56	16.52	4.13	0.69
spinal cord, adult, donor10252	10159-103A6	21.29	14.19	2.37	1.18
spinal cord, adult, donor10258	10369-105F9	40.12	28.36	3.46	0.69
spinal cord, fetal, donor1	10056-101H2	28.66	9.15	7.93	2.44
spinal cord, newborn, donor10223	10359-105E8	23.42	19.75	2.30	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.91	16.73	2.09	0.45
spleen, adult, pool1	10025-101D7	15.42	10.24	1.21	0.33
spleen, fetal, pool1	10044-101F8	10.09	6.52	1.03	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	40.47	40.47	4.97	1.76
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.79	18.61	2.47	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.86	34.25	4.19	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.48	33.62	6.65	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.82	37.93	6.19	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	73.28	73.28	4.24	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.27	21.58	3.38	0.85
stomach, fetal, donor1	10062-101H8	11.75	16.02	2.14	1.07
submaxillary gland, adult	10202-103F4	18.80	10.82	2.85	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	26.38	9.35	2.70	1.45
substantia nigra, adult, donor10258	10371-105G2	26.38	21.72	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.14	15.54	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.06	43.10	7.34	9.17
temporal lobe, adult, pool1	10031-101E4	10.94	5.00	1.02	1.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.92	14.25	3.56	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	20.66	10.55	1.32	2.20
tenocyte, donor1	11763-123H8	25.14	25.48	5.59	3.84
tenocyte, donor2	11765-123I1	14.50	17.55	4.96	0.76
tenocyte, donor3	11768-123I4	24.46	28.54	3.71	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	71.55	81.92	8.50	6.29
teratocarcinoma cell line:NCR-G1	10798-110I6	47.94	28.67	2.00	2.31
teratocarcinoma cell line:PA-1	10807-111A6	58.74	40.29	3.56	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	68.81	63.98	7.11	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.53	19.29	3.03	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	28.25	22.90	3.60	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	67.42	66.12	5.86	1.95
testis, adult, pool1	10026-101D8	12.03	7.73	1.61	9.23
testis, adult, pool2	10096-102C6	14.43	14.89	1.80	9.47
thalamus - adult, donor10196	10168-103B6	24.29	15.46	2.21	0.00
thalamus, adult, donor10252	10154-103A1	27.51	10.00	1.25	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	40.03	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.36	9.72	2.14	0.16
thalamus, newborn, donor10223	10366-105F6	19.56	20.14	4.60	2.88
throat, adult	10209-103G2	18.48	13.23	1.00	1.25
throat, fetal, donor1	10061-101H7	29.56	17.37	3.05	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	45.31	41.14	6.56	2.19
thymus, adult, pool1	10027-101D9	19.19	11.73	1.99	2.09
thymus, fetal, pool1	10043-101F7	22.24	16.62	1.97	3.01
thyroid carcinoma cell line:KHM-5M	10776-110G2	100.52	75.12	7.45	5.98
thyroid carcinoma cell line:TCO-1	10783-110G9	47.49	31.15	2.24	1.96
thyroid, adult, pool1	10028-101E1	20.06	12.78	2.61	1.68
thyroid, fetal, donor1	10060-101H6	27.42	18.72	3.16	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	0.00	0.00	0.00
tongue, adult	10203-103F5	29.77	19.30	2.09	1.16
tongue, fetal, donor1	10059-101H5	66.21	29.95	8.28	1.58
tonsil, adult, pool1	10047-101G2	19.63	13.32	2.10	1.00
trachea, adult, pool1	10029-101E2	18.40	13.09	1.39	0.90
trachea, fetal, donor1	10058-101H4	25.01	15.00	2.69	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.36	28.70	3.54	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	30.90	26.85	3.14	4.56
transitional-cell carcinoma cell line:JMSU1	10492-107B6	46.85	28.05	4.07	2.82
tridermal teratoma cell line:HGRT	10694-109G1	7.61	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.16	22.86	1.19	1.02
umbilical cord, fetal, donor1	10057-101H3	14.61	10.43	2.09	4.17
uterus, adult, pool1	10100-102D1	18.94	8.87	0.17	1.37
uterus, fetal, donor1	10055-101H1	25.08	23.55	3.58	1.54
vagina, adult	10204-103F6	10.34	5.17	0.65	0.65
vein, adult	10191-103E2	12.28	9.43	1.53	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.51	20.03	3.20	0.53